Finally, Haddad et al. (9) showed a trend of decreased RPSA expression in mice with a MYPBC3 mutation causing hypertrophic cardiomyopathy (HCM), yet those mice showed no difference in subcellular RPSA localization. Here, RPSA is linked to hypertrophic cardiomyopathy.